Range Low Price High Price Comment
30 days $17.56 $26.56 Thursday, 28th Mar 2024 ACAD stock ended at $18.49. This is 1.59% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 2.49% from a day low at $18.05 to a day high of $18.50.
90 days $17.56 $31.82
52 weeks $17.56 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2023-08-23 $29.14 $29.35 $28.59 $28.64 882 569
2023-08-22 $30.30 $30.31 $29.06 $29.09 940 503
2023-08-21 $29.33 $30.49 $28.75 $30.32 1 896 694
2023-08-18 $28.60 $29.50 $28.49 $29.33 1 187 033
2023-08-17 $29.23 $29.26 $28.66 $28.90 1 739 911
2023-08-16 $29.06 $29.99 $28.92 $29.25 2 020 956
2023-08-15 $28.07 $28.74 $27.76 $28.72 1 205 512
2023-08-14 $27.29 $28.31 $26.57 $28.01 1 336 224
2023-08-11 $26.60 $27.54 $26.56 $27.37 917 551
2023-08-10 $26.63 $26.77 $26.28 $26.65 1 079 276
2023-08-09 $26.72 $26.72 $26.11 $26.59 1 002 808
2023-08-08 $26.83 $27.15 $26.45 $26.72 1 319 859
2023-08-07 $27.17 $27.17 $26.52 $26.80 1 398 949
2023-08-04 $27.20 $27.48 $26.95 $27.19 1 559 298
2023-08-03 $27.98 $28.29 $27.04 $27.20 3 738 181
2023-08-02 $28.75 $29.53 $28.71 $29.20 1 707 063
2023-08-01 $29.25 $29.34 $28.66 $28.94 1 862 853
2023-07-31 $29.23 $29.74 $28.91 $29.24 1 768 882
2023-07-28 $28.75 $29.24 $27.90 $29.04 3 179 807
2023-07-27 $29.48 $29.48 $28.82 $29.02 950 770
2023-07-26 $29.59 $29.61 $29.02 $29.16 963 261
2023-07-25 $29.94 $30.26 $29.50 $29.60 1 128 328
2023-07-24 $30.88 $30.92 $29.93 $30.02 1 578 999
2023-07-21 $31.59 $31.60 $30.63 $30.80 2 631 399
2023-07-20 $31.96 $32.29 $31.03 $31.26 2 385 793
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT